CD8A and neoplasm: Beyond CAR, introduction of a tumor-specific αβ TCR and the corresponding CD4 or CD8 co-receptor for recognition of HLA-restricted tumor antigen in γδ T cells led to their pronounced cytokine secretion and cytolytic effects against leukemia (105).